Loading clinical trials...
Loading clinical trials...
A Phase 1 Clinical Trial to Evaluate the Drug-Drug Interaction Between R1_PBK_M2301 and R2_PBK_M2301
Conditions
Interventions
R1_PBK_M2301(Levocloperastine 60mg)
R2_PBK_M2301 (Pelargonium sidoides extract)
Locations
1
South Korea
H+ Yangji Hospital
Seoul, Seoul, South Korea
Start Date
June 1, 2025
Primary Completion Date
July 30, 2025
Completion Date
August 30, 2025
Last Updated
September 12, 2025
Lead Sponsor
Pharmbio Korea Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions